IMCR

Bullish

How Investors May Respond To Immunocore (IMCR) Q1 Profitability and ESOP-Linked Share Registration

Immunocore Holdings plc (IMCR) reported a profitable Q1 2026 with revenues of US$106.68 million and net income of US$12.97 million, alongside a US$76....

Simply Wall Street 1 week ago 0

Bullish

Immunocore (IMCR) Is Up 9.7% After Strong Q1 Results And KIMMTRAK Survival Data Release

Immunocore Holdings (IMCR) recently reported strong Q1 2026 results, with significant revenue and net income, alongside positive five-year survival da...

Simply Wall Street 3 weeks ago 0